Literature DB >> 12884096

Carcinoembryonic antigen to detect hepatic metastases of colorectal cancers.

Suat Kutun1, Alper Celik, Celal Hatiboglu, Haluk Ulucanlar, Abdullah Cetin.   

Abstract

PURPOSE: The spread of colorectal carcinoma (CRC) affects both staging and treatment. In this prospective study we examined the relationship between carcinoembryonic antigen (CEA) levels in bile, mesenteric venous blood, and peripheral venous blood, and the presence of occult hepatic metastases in patients with CRC.
METHODS: Sixty patients who underwent elective surgery at Ankara Oncology Hospital were voluntarily assigned to one of the three groups of 20 patients each. The control group consisted of patients operated on for benign biliary disorders, the second group consisted of patients with CRC without metastases, and the third group consisted of patients with CRC and isolated liver metastases. Bile, mesenteric venous blood, and peripheral venous blood was collected perioperatively for the measurement of CEA levels.
RESULTS: The bile CEA levels were significantly higher in the CRC patients with metastases than in those without metastases and the controls. The CEA levels in the mesenteric venous blood and peripheral venous blood were significantly higher in the two groups of CRC patients than in the control group. Overt hepatic metastases later developed in seven patients from the CRC without metastases group who had relatively high CEA levels, but the difference was not significant.
CONCLUSION: The CEA levels in bile, mesenteric venous blood, and peripheral venous blood were increased in patients with CRC and liver metastases. The detection of elevated CEA levels in bile taken at surgery did not herald metachronous hepatic metastases in CRC patients without liver metastases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12884096     DOI: 10.1007/s00595-003-2546-y

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  5 in total

1.  The serum level of carcinoembryonic antigen in drainage venous blood is not a sensitive predictor of metachronous hepatic metastasis for patients with colorectal cancer.

Authors:  Masashi Haraguchi; Fumihiko Fujita; Yasuhiro Torashima; Takamitsu Inokuma; Yoshitsugu Tajima; Takashi Kanematsu
Journal:  Surg Today       Date:  2010-07-30       Impact factor: 2.549

2.  Value of carcinoembryonic antigen assay in predicting hepatic metastases, local recurrence, and survival after curative resection of colorectal cancer.

Authors:  Ioannis Kanellos; Emmanouil Zacharakis; Haralampos Demetriades; Emmanouil Christoforidis; Dimitrios Kanellos; Manousos-Georgios Pramateftakis; Dimitrios Betsis
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

3.  Can biliary carcinoembryonic antigen identify colorectal cancer patients with occult hepatic metastases?

Authors:  Giovanni Li Destri; Raffaele Lanteri; Marco Santangelo; Benedetto Torrisi; Antonio Di Cataldo; Stefano Puleo
Journal:  World J Surg       Date:  2006-08       Impact factor: 3.352

4.  Combined transductional untargeting/retargeting and transcriptional restriction enhances adenovirus gene targeting and therapy for hepatic colorectal cancer tumors.

Authors:  Hua-Jung Li; Maaike Everts; Masato Yamamoto; David T Curiel; Harvey R Herschman
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

5.  A Silicon Nanowire Array Biosensor Fabricated by Complementary Metal Oxide Semiconductor Technique for Highly Sensitive and Selective Detection of Serum Carcinoembryonic Antigen.

Authors:  Xun Yang; Yun Fan; Zhenhua Wu; Chaoran Liu
Journal:  Micromachines (Basel)       Date:  2019-11-11       Impact factor: 2.891

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.